The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.

By J. Funder, R. Carey, F. Mantero, M. Murad, M. Reincke, H. Shibata, M. Stowasser, W. Young. Journal of Clinical Endocrinology and Metabolism, 2016

2,489 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Surgery

View Paper: https://www.semanticscholar.org/paper/36716f26ebd3b8e468f352d9132208c41e5688c0

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. S. Monticone
2. F. D’Ascenzo
3. C. Moretti
4. F. Veglio
5. F. Gaita
6. T. Williams
7. P. Mulatero
8. F. Buffolo

Citations in the corpus

• Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. (2018, background): “The Endocrine Society has in 2016 updated their clinical practice guidelines regarding screening, diagnosing, and treatment of primary aldosteronism (9).”
• Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice. (2017, methodology): “The ARR is the most reliable means to screen for PA, but a unique cutoff is difficult to define because of the wide variability of laboratory assays and population-specific characteristics (4,5).”